Literature DB >> 11850044

High-efficiency adenovirus-mediated in vivo gene transfer into neonatal and adult rodent skeletal muscle.

Mohan K Sapru1, Kathleen M McCormick, Bayer Thimmapaya.   

Abstract

Several methodological limitations have emerged in the use of viral gene transfer into skeletal muscle. First, because the nuclei of mature muscle fibers do not undergo division, the use of strategies involving replicative integration of exogenous DNA is greatly limited. Another important limitation concerns the maturation-dependent loss in muscle fiber infectivity with adenoviral vectors. In this study, we investigated the possibility that high-titer infections with recombinant adenovirus, expressing a foreign marker gene under the control of a strong viral promoter, can significantly improve the efficiency of gene transfer in vivo into neonatal and adult rat skeletal muscle. High-titer (2 x 10(10) plaque forming units) intramuscular injection of replication-defective adenovirus vector, expressing green fluorescent protein (GFP) under the control of cytomegalovirus promoter, resulted in GFP expression in 99 +/- 0.34% of fibers in the adult soleus muscle and in approximately 85 +/- 1.44% of fibers in the adult tibialis anterior muscle. Interestingly, reduction in injected adenoviral dose significantly reduced the number of GFP-positive fibers in the adult tibialis anterior muscle, but not in the soleus muscle. However, in neonates, adenoviral infection resulted in GFP expression in 96-99% of the fibers in the tibialis anterior and the gastrocnemius muscles regardless of administered adenoviral dose.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850044     DOI: 10.1016/s0165-0270(01)00518-0

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  7 in total

1.  Imaging of human sodium-iodide symporter gene expression mediated by recombinant adenovirus in skeletal muscle of living rats.

Authors:  Hyun Suk Yang; Heuiran Lee; Sung Jin Kim; Won Woo Lee; You-Jung Yang; Dae Hyuk Moon; Seong-Wook Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-25       Impact factor: 9.236

2.  Robust in vivo transduction of a genetically stable Epstein-Barr virus episome to hepatocytes in mice by a hybrid viral vector.

Authors:  Sean D Gallaher; Jose S Gil; Oliver Dorigo; Arnold J Berk
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

3.  A new role for sterol regulatory element binding protein 1 transcription factors in the regulation of muscle mass and muscle cell differentiation.

Authors:  Virginie Lecomte; Emmanuelle Meugnier; Vanessa Euthine; Christine Durand; Damien Freyssenet; Georges Nemoz; Sophie Rome; Hubert Vidal; Etienne Lefai
Journal:  Mol Cell Biol       Date:  2009-12-22       Impact factor: 4.272

4.  PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression.

Authors:  Rong Qi; Yu Gao; Yin Tang; Rui-Rui He; Tao-Le Liu; Yun He; Sheng Sun; Bo-Yu Li; Yang-Bing Li; George Liu
Journal:  AAPS J       Date:  2009-05-29       Impact factor: 4.009

5.  Magnetofection Enhances Adenoviral Vector-based Gene Delivery in Skeletal Muscle Cells.

Authors:  Andrea Soledad Pereyra; Olga Mykhaylyk; Eugenia Falomir Lockhart; Jackson Richard Taylor; Osvaldo Delbono; Rodolfo Gustavo Goya; Christian Plank; Claudia Beatriz Hereñu
Journal:  J Nanomed Nanotechnol       Date:  2016-04-05

6.  Synthesis and evaluation of L-arabinose-based cationic glycolipids as effective vectors for pDNA and siRNA in vitro.

Authors:  Bo Li; Wanrong Guo; Fan Zhang; Meiyan Liu; Shang Wang; Zhonghua Liu; Shuanglin Xiang; Youlin Zeng
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

7.  PPARβ/δ Agonism Upregulates Forkhead Box A2 to Reduce Inflammation in C2C12 Myoblasts and in Skeletal Muscle.

Authors:  Wendy Wen Ting Phua; Wei Ren Tan; Yun Sheng Yip; Ivan Dongzheng Hew; Jonathan Wei Kiat Wee; Hong Sheng Cheng; Melvin Khee Shing Leow; Walter Wahli; Nguan Soon Tan
Journal:  Int J Mol Sci       Date:  2020-03-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.